# CRESCENT BIOPHARMA INC. (CBIOXXXX)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CBIOXXXX/

- Reporting holders: 2
- Reported value: $8.5M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Boxer Capital Management, LLC](https://holderbook.com/funds/2018299-boxer-capital-management-llc/) | $8.2M | 453,686 | 0.6% | 2 |
| [Quadrature Capital Ltd](https://holderbook.com/funds/1651424-quadrature-capital-ltd/) | $346.1K | 19,227 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 2 | $8.5M |
| Q1 2026 | 3 | $15.4M |
| Q4 2025 | 2 | $4.4M |
| Q1 2025 | 1 | $55.0K |
| Q4 2024 | 2 | $13.5K |
| Q3 2024 | 1 | $355 |
| Q2 2024 | 2 | $129.9K |
| Q1 2024 | 2 | $527.3K |
| Q4 2023 | 2 | $215.0K |
| Q3 2023 | 2 | $41.5K |
| Q2 2023 | 2 | $62.3K |
| Q1 2023 | 2 | $172.8K |